Insider buying
~$18K13K sh @ $1.45
Traded Dec 6, 2024 · filed 5 days later
An An2 Therapeutics director paid $18K out of pocket for An2 Therapeutics shares. 2 other people at An2 Therapeutics bought some too, in the same month.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Nov 27, 2024 · Filed Nov 28, 2024
An An2 Therapeutics director paid $35K out of pocket for An2 Therapeutics shares. 2 other people at An2 Therapeutics bought some too, in the same month.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$35,418
Shares × reported transaction price
$25K–$100K
+4.2%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
First purchase in 0 months
Confirmed open-market purchases by the same insider in the available history
No
Compared with 6 earlier confirmed purchases
3 distinct insiders in 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
14 days after results of Nov 13, 2024, 118 days before results of Mar 25, 2025
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −13.8% | +0.9% | −14.6% |
| 30 days | −15.6% | −2.4% | −13.2% |
| 90 days | −33.5% | −2.9% | −30.6% |
| 180 days | −31.1% | −2.5% | −28.7% |
| 365 days | −37.1% | +12.9% | −50.0% |
Past results only. Not a forecast.
Insider buying
Traded Dec 6, 2024 · filed 5 days later
An An2 Therapeutics director paid $18K out of pocket for An2 Therapeutics shares. 2 other people at An2 Therapeutics bought some too, in the same month.
Insider buying
Traded Dec 6, 2024 · filed 5 days later
An An2 Therapeutics director paid $9.4K out of pocket for An2 Therapeutics shares. 2 other people at An2 Therapeutics bought some too, in the same month.
Insider buying
Traded Dec 9, 2024 · filed 2 days later
An An2 Therapeutics director paid $18K out of pocket for An2 Therapeutics shares. 2 other people at An2 Therapeutics bought some too, in the same month.
Robin Shane Readnour, Director's past purchases, 90 days after disclosure: 3 buys, median −18.2 pts vs S&P 500, beat it 0 of 3 times. Past results, not a forecast.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.